Cite
Proteolysis-targeting chimaeras (PROTACs) as pharmacological tools and therapeutic agents: advances and future challenges.
MLA
Chao Wang, et al. “Proteolysis-Targeting Chimaeras (PROTACs) as Pharmacological Tools and Therapeutic Agents: Advances and Future Challenges.” Journal of Enzyme Inhibition & Medicinal Chemistry, vol. 37, no. 1, Dec. 2022, pp. 1667–93. EBSCOhost, https://doi.org/10.1080/14756366.2022.2076675.
APA
Chao Wang, Yujing Zhang, Tingting Zhang, Lingyu Shi, Zhongmin Geng, & Dongming Xing. (2022). Proteolysis-targeting chimaeras (PROTACs) as pharmacological tools and therapeutic agents: advances and future challenges. Journal of Enzyme Inhibition & Medicinal Chemistry, 37(1), 1667–1693. https://doi.org/10.1080/14756366.2022.2076675
Chicago
Chao Wang, Yujing Zhang, Tingting Zhang, Lingyu Shi, Zhongmin Geng, and Dongming Xing. 2022. “Proteolysis-Targeting Chimaeras (PROTACs) as Pharmacological Tools and Therapeutic Agents: Advances and Future Challenges.” Journal of Enzyme Inhibition & Medicinal Chemistry 37 (1): 1667–93. doi:10.1080/14756366.2022.2076675.